Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2457669rdf:typepubmed:Citationlld:pubmed
pubmed-article:2457669lifeskim:mentionsumls-concept:C0001175lld:lifeskim
pubmed-article:2457669lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:2457669lifeskim:mentionsumls-concept:C0449435lld:lifeskim
pubmed-article:2457669pubmed:issue4lld:pubmed
pubmed-article:2457669pubmed:dateCreated1988-9-29lld:pubmed
pubmed-article:2457669pubmed:abstractTextInterferons are natural proteins with important regulatory functions. Impairment of their production may help to explain many of the immunologic abnormalities and disease susceptibilities of AIDS patients, while excessive production of an unusual type of interferon may explain some of the systemic symptoms associated with the syndrome. In a subset of patients, alpha interferons may have therapeutic potential against a major complication of the syndrome, Kaposi's sarcoma. Finally, both alpha and gamma interferons have potential, but as yet unexplored roles to play in the treatment of HTLV-III/LAV viremia and in the control of secondary infectious complications of the syndrome.lld:pubmed
pubmed-article:2457669pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457669pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457669pubmed:languageenglld:pubmed
pubmed-article:2457669pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457669pubmed:citationSubsetIMlld:pubmed
pubmed-article:2457669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2457669pubmed:statusMEDLINElld:pubmed
pubmed-article:2457669pubmed:issn0730-8485lld:pubmed
pubmed-article:2457669pubmed:authorpubmed-author:OettgenH FHFlld:pubmed
pubmed-article:2457669pubmed:authorpubmed-author:TingNNlld:pubmed
pubmed-article:2457669pubmed:authorpubmed-author:KrownS ESElld:pubmed
pubmed-article:2457669pubmed:authorpubmed-author:Vadhan-RajSSlld:pubmed
pubmed-article:2457669pubmed:issnTypePrintlld:pubmed
pubmed-article:2457669pubmed:volume3lld:pubmed
pubmed-article:2457669pubmed:ownerNLMlld:pubmed
pubmed-article:2457669pubmed:authorsCompleteYlld:pubmed
pubmed-article:2457669pubmed:pagination681-91lld:pubmed
pubmed-article:2457669pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2457669pubmed:meshHeadingpubmed-meshheading:2457669-...lld:pubmed
pubmed-article:2457669pubmed:meshHeadingpubmed-meshheading:2457669-...lld:pubmed
pubmed-article:2457669pubmed:meshHeadingpubmed-meshheading:2457669-...lld:pubmed
pubmed-article:2457669pubmed:meshHeadingpubmed-meshheading:2457669-...lld:pubmed
pubmed-article:2457669pubmed:year1987lld:pubmed
pubmed-article:2457669pubmed:articleTitleInterferon in AIDS.lld:pubmed
pubmed-article:2457669pubmed:affiliationMemorial Sloan-Kettering Cancer Center, New York, NY 10021.lld:pubmed
pubmed-article:2457669pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2457669pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2457669pubmed:publicationTypeReviewlld:pubmed
pubmed-article:2457669pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed